Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Epicenter who wrote (1712)	2/8/1999 11:04:00 PM
From: Ed Ajootian	Read Replies (2) \| Respond to of 10280

Epicenter, Thanks for the offer, think I'll use this as an opportunity to put out a "wish list" of questions: 1) When can we expect some news on the Allegra patent interference suit? 2) When do they expect to file their next NDA for other forms of Xopenex delivery? Is this contingent on getting this nebulized form approved first? 3) Their latest quarterly mail-out said they got Formoterol by Phase II I believe. What is the current timetable to getting an NDA filed on that one? 4) What is management's philosophy re: stock splits and the timing thereof? 5) Are there any plans for using their stock as a form of "currency" with which to make strategic acquisitions? I obviously can't expect you to get answers to all these but if any of these issues are addressed I'd be interested to know what they had to say about them. Would also appreciate any comments from the cyber-peanut galley (i.e. this thread!). My understanding is that this event is a "coming out party" of sorts for SEPR. This is a Health Care conference and not a Biotech conference. SEPR is gonna be the little kid on the block here, amongst the Merck's and Pfizers of the world. Would be interested to see if you can confirm or deny my understanding about this. If SEPR is gonna start to be compared with the huge pharmaceutical companies, its $3 Bill. market cap. is gonna start to look mighty tiny real fast! I am betting that this conference is gonna spark a nice, slow, point-a-day rally all the way to $120.